ATE506079T1 - Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen - Google Patents

Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen

Info

Publication number
ATE506079T1
ATE506079T1 AT08075902T AT08075902T ATE506079T1 AT E506079 T1 ATE506079 T1 AT E506079T1 AT 08075902 T AT08075902 T AT 08075902T AT 08075902 T AT08075902 T AT 08075902T AT E506079 T1 ATE506079 T1 AT E506079T1
Authority
AT
Austria
Prior art keywords
naphthalimide
tissue
bonding
tissues
naphthalimide compounds
Prior art date
Application number
AT08075902T
Other languages
English (en)
Inventor
Ronald E Utecht
Kaia L Kloster
Millard M Judy
Kevin J Vaska
James L Matthews
Original Assignee
Photobiomed Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photobiomed Corp filed Critical Photobiomed Corp
Application granted granted Critical
Publication of ATE506079T1 publication Critical patent/ATE506079T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N2005/0602—Apparatus for use inside the body for treatment of blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08075902T 2003-11-05 2004-11-05 Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen ATE506079T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51761803P 2003-11-05 2003-11-05

Publications (1)

Publication Number Publication Date
ATE506079T1 true ATE506079T1 (de) 2011-05-15

Family

ID=34572957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08075902T ATE506079T1 (de) 2003-11-05 2004-11-05 Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen

Country Status (7)

Country Link
US (9) US7514399B2 (de)
EP (2) EP1689441A1 (de)
AT (1) ATE506079T1 (de)
CA (1) CA2586320A1 (de)
DE (1) DE602004032400D1 (de)
ES (1) ES2371501T3 (de)
WO (1) WO2005044309A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003282683A1 (en) * 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
ATE506079T1 (de) * 2003-11-05 2011-05-15 Photobiomed Corp Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen
US20060246020A1 (en) * 2005-04-29 2006-11-02 Cole Curtis A Topical composition detection
BRPI0807065A2 (pt) * 2007-01-31 2017-03-21 Allergan Inc biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos
EP1955710A1 (de) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Wässrige Zusammensetzung, die Chitosan und eine säurehaltige Substanz umfasst
GB0721194D0 (en) * 2007-10-29 2007-12-05 Ucl Business Plc Luminescence
WO2009064838A1 (en) * 2007-11-15 2009-05-22 Amgen, Inc. Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
CN103547226B (zh) 2011-01-28 2018-04-17 通用医疗公司 用于皮肤再表面化的装置
WO2012103483A2 (en) 2011-01-28 2012-08-02 The General Hospital Corporation Apparatus and method for tissue biopsy
US9561051B2 (en) 2011-01-28 2017-02-07 The General Hospital Corporation Method and apparatus for discontinuous dermabrasion
ES2693162T3 (es) 2011-07-21 2018-12-07 The General Hospital Corporation Instrumental para dañar y eliminar grasa
WO2014015274A1 (en) * 2012-07-20 2014-01-23 The General Hospital Corporation Methods for tissue passivation
WO2014022807A2 (en) * 2012-08-03 2014-02-06 Alumend, Llc Compositions and methods of using the compositions for plaque softening
WO2014113450A1 (en) 2013-01-16 2014-07-24 Alumend, Llc Decreasing inflammatory response in a blood vessel
EP4039236A1 (de) 2013-02-20 2022-08-10 Cytrellis Biosystems, Inc. System zur hautstraffung
US10131635B2 (en) 2013-03-15 2018-11-20 Alumend, Llc Compositions and methods of using the compositions for plaque softening
EP3763371B1 (de) 2013-03-15 2024-03-06 Alumend, LLC Verfahren zur akuten wiederherstellung von vaskulärer compliance
AU2014259645B2 (en) 2013-05-03 2019-05-02 Cytrellis Biosystems, Inc. Microclosures and related methods for skin treatment
EP3030175B1 (de) 2013-08-09 2023-10-04 Cytrellis Biosystems, Inc. Vorrichtungen zur hautbehandlung mittels nichtthermischer gewebeablation
US10953143B2 (en) 2013-12-19 2021-03-23 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
CN103864686B (zh) * 2014-03-14 2015-09-30 中国海洋石油总公司 一种萘酰亚胺季铵盐的微波常压合成方法
BR112017009805A2 (pt) 2014-11-14 2017-12-26 Cytrellis Biosystems Inc dispositivos e métodos para ablação da pele
KR102561605B1 (ko) 2016-03-29 2023-08-01 사이트렐리스 바이오시스템즈, 인크. 미용 피부 리설페이싱용 디바이스 및 방법
KR102515836B1 (ko) 2016-09-21 2023-03-31 사이트렐리스 바이오시스템즈, 인크. 미용 피부 리설페이싱용 디바이스 및 방법
US11344507B2 (en) 2019-01-08 2022-05-31 Alumend, Llc Topical compositions containing low molecular weight chitosan derivatives
EP4010058A1 (de) 2019-08-07 2022-06-15 W.L. Gore & Associates, Inc. Ballonfreisetzungsvorrichtung für ein lichtaktivierbares behandlungsmedium
CN111978433A (zh) * 2020-07-20 2020-11-24 南京林业大学 N-壳聚糖基-4-羟基-1,8-萘二甲酰亚胺荧光材料及其制备方法与应用
US20240238611A1 (en) 2021-06-08 2024-07-18 W. L. Gore & Associates, Inc. Treatment media delivery device and methods for targeted delivery thereof
CN113856005A (zh) * 2021-09-26 2021-12-31 复旦大学附属中山医院 一种促进组织修复和纤维连接的药物涂层球囊导管组件及其使用方法
CN116265036A (zh) * 2021-12-17 2023-06-20 杭州矩正医疗科技有限公司 一种原位生成血管支架的球囊导管系统
CN116407739A (zh) * 2021-12-29 2023-07-11 杭州矩正医疗科技有限公司 载药球囊导管
US12295949B2 (en) 2022-08-07 2025-05-13 Alumend, Llc Treatment of the gastrointestinal tract with dimeric naphthalimide compounds
JP2025530802A (ja) * 2022-09-02 2025-09-17 杭州矩正医療科技有限公司 薬物載置バルーンカテーテルおよびその作製方法、バルーンカテーテルシステムおよび血管インサイチューステント生成方法
CN115737914B (zh) * 2022-11-25 2024-02-06 杭州矩正医疗科技有限公司 一种具有血管修复功能的感光材料制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2574184B1 (fr) * 1984-11-30 1988-04-22 Centre Nat Rech Scient Composes fluorescents, derives d'(amino-4 disulfonato-3,6) naphtalimide, leur application aux dosages immunologiques en polarisation de fluorescence
US5177083A (en) 1986-07-03 1993-01-05 The Scripps Clinic And Research Foundation Drugs effective against retroviruses
US5308604A (en) * 1989-04-19 1994-05-03 Deutsches Krebsforschungsinstitut Conjugates for tumor localization and/or tumor therapy
BR9306038A (pt) * 1992-02-28 1998-01-13 Univ Texas Hidrogéis biodegradáveis fotopolimerizáveis como materiais de contato de tecidos e condutores de liberação controlada
US5235045A (en) * 1992-03-19 1993-08-10 Microbiomed Corporation Non-azo naphthalimide dyes
US5766600A (en) * 1993-08-09 1998-06-16 Microbiomed Corporation Non-azo naphtalimide dyes and uses for same
US5431639A (en) * 1993-08-12 1995-07-11 Boston Scientific Corporation Treating wounds caused by medical procedures
IL110460A (en) * 1993-08-18 2001-01-11 Basf Ag Bis-naphthalimides, their preparation and pharmaceutical compositions containing them
US6410505B1 (en) * 1999-06-28 2002-06-25 Microbiomed Corp. Dimeric non-azo naphthalimides and uses for the same
US5917045A (en) 1995-06-07 1999-06-29 Microbiomed Corporation Dimeric non-azo naphthalimides and uses for same
EP0851768B1 (de) * 1995-09-01 2002-04-24 University of Washington Interaktive molekulare konjugate
GB9920774D0 (en) * 1999-09-03 1999-11-03 Avecia Ltd Polymer
US20030206958A1 (en) * 2000-12-22 2003-11-06 Cattaneo Maurizio V. Chitosan biopolymer for the topical delivery of active agents
AU2001240054B2 (en) * 2000-03-07 2005-08-11 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
KR20030038814A (ko) * 2000-10-11 2003-05-16 타게솜, 인크. 표적 치료제
AU2003217782A1 (en) * 2002-02-27 2003-09-09 The Government Of The United States Of America, Representated By The Secretary, Deparment Of Health Dna-binding polyamide drug conjugates
ATE506079T1 (de) * 2003-11-05 2011-05-15 Photobiomed Corp Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use

Also Published As

Publication number Publication date
US20050113288A1 (en) 2005-05-26
WO2005044309A1 (en) 2005-05-19
CA2586320A1 (en) 2005-05-19
US8741270B2 (en) 2014-06-03
US20090181927A1 (en) 2009-07-16
US8546384B2 (en) 2013-10-01
EP2047866B1 (de) 2011-04-20
DE602004032400D1 (de) 2011-06-01
EP1689441A1 (de) 2006-08-16
US8242114B2 (en) 2012-08-14
US20140350453A1 (en) 2014-11-27
US20190241680A1 (en) 2019-08-08
US20130165970A1 (en) 2013-06-27
US9822189B2 (en) 2017-11-21
US7514399B2 (en) 2009-04-07
US9125938B2 (en) 2015-09-08
US20130230472A1 (en) 2013-09-05
US10053521B2 (en) 2018-08-21
US10851185B2 (en) 2020-12-01
US20130045171A1 (en) 2013-02-21
US8632565B2 (en) 2014-01-21
ES2371501T3 (es) 2012-01-03
US20180079833A1 (en) 2018-03-22
US20160068614A1 (en) 2016-03-10
EP2047866A1 (de) 2009-04-15

Similar Documents

Publication Publication Date Title
ATE506079T1 (de) Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen
US20220265828A1 (en) Biophotonic materials and uses thereof
CY1110505T1 (el) Ανθρωπινα αντισωματα dr4 και χρησεις αυτων
DE60142084D1 (de) Anwendung von glp-2 in verbindung mit einem anderen therapeutischen mittel in knochenkrankheiten
ATE476924T1 (de) Vorrichtungen zur behandlung von empfänglicher plaque
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
CY1119480T1 (el) Παραγωγα ρετιναλης και μεθοδοι για τη χρηση αυτων για τη θεραπευτικη αντιμετωπιση διαταραχων της ορασης
DE60329126D1 (de) Konjugate mit biologisch abbaubarem polymer und verwendung dafür
ATE296124T1 (de) Haut/haar-äquivalent mit rekonstruierten papillen
BR0212079A (pt) Polìmero superabsorvente, método para produzir uma partìcula de polìmero superabsorvente, compósito absorvente, e, artigo absorvente
DE60314565D1 (de) Kosmetische Hautpflegezusammensetzungen
DK1227126T3 (da) Gummisammensætning anvendt til en gummiprop til et medikament eller til en medicinsk behandling eller dets tævrbundne produkt
ATE424418T1 (de) Kohlenhydratbindungsdomäne enthaltende fusionsproteine zur verabreichung von therapeutischen und anderen stoffen und zusammensetzungen in denen die fusionsproteine enthalten sind
BRPI0506665A (pt) processos e composições para o tratamento de alterações de pele associadas com envelhecimento e dano ambiental
ATE489382T1 (de) Benzoxazinonderivate, deren herstellung und verwendung als arzneimittel
CL2009001077A1 (es) Vehiculo particulado polimerico que comprende un agente biologico en fase acuosa en un lumen hueco; procedimiento para suministrar una proteina en el ojo; composicion farmaceutica que comprende dicho vehiculo; y su uso para profilaxis y tratar enfermedades o trastornos del ojo.
CA2952954A1 (en) Biophotonic compositions comprising halogen and uses thereof
Chan Biomedical applications of photochemistry
ATE220914T1 (de) Lipide enthaltende sojaextrakte, verfahren zu deren herstellung und pharmazeutische und kosmetische zusammensetzung
BRPI0517495A (pt) composição, processo de preparação da composição, uso de uma composição e processo de tratamento cosmético
EP1782824A3 (de) Pharmazeutische Zusammensetzungen, die Diaminooxidase enthalten
DE60215496D1 (de) Kosmetische zusammensetzung zur nagelpflege, ohne phthalat, ohne kampfer und keine aromatische lösungsmittel
ATE494307T1 (de) Neoplasma-spezifische antikörper und deren verwendungen
ATE388678T1 (de) Chirurgischer tupfer mit einem identifizierungkontrollabschnitt
ATE368687T1 (de) Thrombopoietinproteine mit verbesserten eigenschaften

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties